2012年美国风湿病学会类风湿关节炎治疗推荐中生物制剂的适应证水平：对辛格等人文章的评论 - Suppr | 超能文献

Level of the indication of biologic agents in the 2012 American College of Rheumatology recommendations for the treatment of rheumatoid arthritis: comment on the article by Singh et al.

作者信息

Graudal Niels, Jürgens Gesche

出版信息

Arthritis Care Res (Hoboken). 2013 May;65(5):832. doi: 10.1002/acr.21873.

DOI:10.1002/acr.21873

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Level of the indication of biologic agents in the 2012 American College of Rheumatology recommendations for the treatment of rheumatoid arthritis: comment on the article by Singh et al.2012年美国风湿病学会类风湿关节炎治疗推荐中生物制剂的适应证水平：对辛格等人文章的评论

Arthritis Care Res (Hoboken). 2013 May;65(5):832. doi: 10.1002/acr.21873.

2

American College of Rheumatology treatment guidelines continue to omit guidance on glucocorticoids: comment on the article by Singh et al.美国风湿病学会治疗指南仍未包含关于糖皮质激素的指导意见：对辛格等人文章的评论

Arthritis Care Res (Hoboken). 2012 Oct;64(10):1622. doi: 10.1002/acr.21770.

3

Oral glucocorticoids should be included in any recommendation for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis: comment on the article by Singh et al.在类风湿关节炎治疗中，关于使用非生物和生物改善病情抗风湿药物的任何建议都应包括口服糖皮质激素：对辛格等人文章的评论

Arthritis Care Res (Hoboken). 2012 Oct;64(10):1622-3; author reply 1623-4. doi: 10.1002/acr.21809.

4

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.2008年美国风湿病学会关于使用改善病情抗风湿药和生物制剂治疗类风湿关节炎的建议的2012年更新版。

Arthritis Care Res (Hoboken). 2012 May;64(5):625-39. doi: 10.1002/acr.21641.

5

The 2008 American College of Rheumatology recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: where the rubber meets the road.2008年美国风湿病学会关于非生物和生物改善病情抗风湿药在类风湿关节炎中应用的推荐意见：实际应用情况

Arthritis Rheum. 2008 Jun 15;59(6):757-9. doi: 10.1002/art.23723.

6

Updated recommendations for the treatment of rheumatoid arthritis: another step on a long road.类风湿关节炎治疗的更新建议：漫长道路上的又一步。

Arthritis Care Res (Hoboken). 2012 May;64(5):648-51. doi: 10.1002/acr.21659.

7

Reply: To PMID 22473917.回复：致PMID 22473917。

Arthritis Care Res (Hoboken). 2013 May;65(5):832-3. doi: 10.1002/acr.21872.

8

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis.美国风湿病学会2008年关于类风湿关节炎中使用非生物和生物改善病情抗风湿药物的建议。

Arthritis Rheum. 2008 Jun 15;59(6):762-84. doi: 10.1002/art.23721.

9

Recommendations in the American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis Related to the Use of Biologic Agents in Patients With a History of Cancer Need Reconsideration: Comment on the Article by Singh et al.美国风湿病学会类风湿关节炎治疗指南中关于有癌症病史患者使用生物制剂的建议需要重新审视：对辛格等人文章的评论

Arthritis Care Res (Hoboken). 2016 May;68(5):724. doi: 10.1002/acr.22863.

10

Recommendations in the American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis Related to the Use of Biologic Agents in Patients With a History of Cancer Need Reconsideration: Comment on the Article by Singh et al.美国风湿病学会类风湿关节炎治疗指南中关于有癌症病史患者使用生物制剂的建议需重新考量：对辛格等人文章的评论

Arthritis Rheumatol. 2016 May;68(5):1315-6. doi: 10.1002/art.39633.

引用本文的文献

1

Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial.肿瘤坏死因子抑制剂与传统改善病情抗风湿药物联合强化治疗用于确诊类风湿关节炎的疗效比较：TACIT非劣效性随机对照试验

BMJ. 2015 Mar 13;350:h1046. doi: 10.1136/bmj.h1046.